🍎 🍕 Less apples, more pizza 🤔 Have you seen Buffett’s portfolio recently?Explore for Free

Stocks slump in August kick-off as data reignites slowdown worries

Published 2024-08-01, 06:15 a/m
© Reuters. FILE PHOTO: Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., June 14, 2024.  REUTERS/Brendan McDermid/File Photo
NDX
-
US500
-
US2000
-
MSFT
-
GOOGL
-
QCOM
-
AMZN
-
NVDA
-
WDC
-
META
-

By Chuck Mikolajczak

NEW YORK (Reuters) - U.S. stocks kicked off August sharply lower after a round of economic data on Thursday spurred concerns the economy may be slowing faster than anticipated while the Federal Reserve maintains a restrictive monetary policy.

Equities initially opened higher, buoyed in part by gains in Meta Platforms after its quarterly results topped expectations and the Facebook (NASDAQ:META) parent issued an upbeat outlook for the third quarter. Its shares closed 5.87% higher as the biggest boost to the S&P 500.

Early gains, however, evaporated after data showed a measure of manufacturing activity from the Institute for Supply Management (ISM) dropped to an eight-month low in July at 46.8, signifying contraction.

"It raises a genuine fear that the Fed is behind on cutting rates," Lou Basenese, president and chief market strategist at MDB (NASDAQ:MDB) Capital in New York.

"Few investors have confidence in the Fed sticking the proverbial soft landing and now the data is starting to support those concerns."

The Dow Jones Industrial Average fell 494.82 points, or 1.21%, to 40,347.97, the S&P 500 lost 75.62 points, or 1.37%, to 5,446.68 and the Nasdaq Composite lost 405.25 points, or 2.30%, to 17,194.15.

August is typically one of the weakest months of the year for stocks.

Other data showed the number of Americans filing new applications for unemployment benefits increased to an 11-month high last week, suggesting some softening in the labor market, although seasonal factors also played a role.

Investors will eye the government payrolls report on Friday for any signs of further weakness in the labor market.

Both the S&P 500 and Nasdaq registered their biggest daily percentage gains since February in the prior session, boosted by a rally in chip shares after the Fed kept rates steady, as expected.

Defensive sectors such as utilities and real estate led gains, as geopolitical concerns over rising tensions in the Middle East boosted the dollar and pulled Treasury yields lower.

Declines in megacap names such as Apple (NASDAQ:AAPL) , down 1.68%, and Amazon (NASDAQ:AMZN) , which lost 1.56% ahead of their quarterly results due after the closing bell weighed heavily on the tech and consumer discretionary indexes, which were among the worst performing of the 11 major S&P sectors.

After the closing bell, Amazon shares lost 4.47% following its quarterly results and outlook.

Of the 342 companies in the S&P 500 that have reported earnings through Thursday morning, 79.2% have topped analyst expectations, according to LSEG data, slightly above the 79% beat rate over the past four quarters. The estimated earnings growth rate for the quarter is 13.3%, up from 10.6% on July 1.

The small-cap Russell 2000 slumped 3.03% for its biggest daily percentage drop since Feb. 13. Small caps have been volatile recently as investors rotate between cheaper names and more expensive stocks.

"Without a good economy, these economically sensitive small stocks just won’t do anything, even with rate cuts," said Steve Sosnick, market strategist Interactive Brokers, Greenwich, Connecticut.

Nvidia (NASDAQ:NVDA) dropped 6.67% in a broader chip stocks selloff sparked by Arm Holdings (NASDAQ:ARM)' conservative revenue forecast and Qualcomm (NASDAQ:QCOM) flagging a revenue hit from the impact of trade curbs. ARM shares plummeted 15.72% while Qualcomm stumbled 9.37% as the PHLX semiconductor index lost 7.14% for its biggest daily percentage drop since March 2020.

Moderna plunged 21.01% after cutting its 2024 sales forecast for COVID-19 and respiratory syncytial virus vaccines by up to 25%.

Eli Lilly (NYSE:LLY) rose 3.5% after trial results showed weight-loss drug Zepbound reduces the risk of hospitalization, death and other outcomes for obese adults with a common type of heart failure.

Declining issues outnumbered advancers by a 2.04-to-1 ratio on the NYSE and on the Nasdaq, declining issues outnumbered advancers by a 3.19-to-1 ratio.

© Reuters. FILE PHOTO: Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., June 14, 2024.  REUTERS/Brendan McDermid/File Photo

The S&P 500 posted 54 new 52-week highs and seven new lows while the Nasdaq Composite recorded 65 new highs and 177 new lows.

Volume on U.S. exchanges was 14.15 billion shares, compared with the 11.71 billion average for the full session over the last 20 trading days.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.